Alyssa Vito

Alyssa Vito

McMaster University

H-index: 9

North America-Canada

About Alyssa Vito

Alyssa Vito, With an exceptional h-index of 9 and a recent h-index of 9 (since 2020), a distinguished researcher at McMaster University, specializes in the field of Radioligand therapy and immuno-oncology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Oncolytic BHV-1 Is Sufficient to Induce Immunogenic Cell Death and Synergizes with Low-Dose Chemotherapy to Dampen Immunosuppressive T Regulatory Cells

IFNAR blockade synergizes with oncolytic VSV to prevent virus-mediated PD-L1 expression and promote antitumor T cell activity

A combination of chemotherapy and oncolytic virotherapy sensitizes colorectal adenocarcinoma to immune checkpoint inhibitors in a cDC1-dependent manner

Response to FEC Chemotherapy and Oncolytic HSV-1 Is Associated with Macrophage Polarization and Increased Expression of S100A8/A9 in Triple Negative Breast Cancer

Immune checkpoint blockade in triple negative breast cancer influenced by B cells through myeloid-derived suppressor cells

Combined radionuclide therapy and immunotherapy for treatment of triple negative breast cancer

Tumor heterogeneity: a great barrier in the age of cancer immunotherapy

Investigating Immunotherapy Treatments and the Immunological Synapse in Triple Negative Breast Cancer

Alyssa Vito Information

University

Position

PhD Candidate

Citations(all)

479

Citations(since 2020)

422

Cited By

136

hIndex(all)

9

hIndex(since 2020)

9

i10Index(all)

9

i10Index(since 2020)

9

Email

University Profile Page

Google Scholar

Alyssa Vito Skills & Research Interests

Radioligand therapy and immuno-oncology

Top articles of Alyssa Vito

Oncolytic BHV-1 Is Sufficient to Induce Immunogenic Cell Death and Synergizes with Low-Dose Chemotherapy to Dampen Immunosuppressive T Regulatory Cells

Cancers

2023/2/17

IFNAR blockade synergizes with oncolytic VSV to prevent virus-mediated PD-L1 expression and promote antitumor T cell activity

Molecular Therapy-Oncolytics

2022/6/16

A combination of chemotherapy and oncolytic virotherapy sensitizes colorectal adenocarcinoma to immune checkpoint inhibitors in a cDC1-dependent manner

International Journal of Molecular Sciences

2022/2/3

Response to FEC Chemotherapy and Oncolytic HSV-1 Is Associated with Macrophage Polarization and Increased Expression of S100A8/A9 in Triple Negative Breast Cancer

Cancers

2021/11/8

Alyssa Vito
Alyssa Vito

H-Index: 5

Yonghong Wan
Yonghong Wan

H-Index: 26

Immune checkpoint blockade in triple negative breast cancer influenced by B cells through myeloid-derived suppressor cells

Communications Biology

2021/7/12

Alyssa Vito
Alyssa Vito

H-Index: 5

Yonghong Wan
Yonghong Wan

H-Index: 26

Combined radionuclide therapy and immunotherapy for treatment of triple negative breast cancer

International journal of molecular sciences

2021/5/3

Alyssa Vito
Alyssa Vito

H-Index: 5

Karen Mossman
Karen Mossman

H-Index: 39

Tumor heterogeneity: a great barrier in the age of cancer immunotherapy

2021/2/15

Alyssa Vito
Alyssa Vito

H-Index: 5

Karen Mossman
Karen Mossman

H-Index: 39

Investigating Immunotherapy Treatments and the Immunological Synapse in Triple Negative Breast Cancer

2021

Alyssa Vito
Alyssa Vito

H-Index: 5

De novo necroptosis creates an inflammatory environment mediating tumor susceptibility to immune checkpoint inhibitors

Communications biology

2020/11/4

Hypoxia-driven immune escape in the tumor microenvironment

2020/4/16

Alyssa Vito
Alyssa Vito

H-Index: 5

Karen Mossman
Karen Mossman

H-Index: 39

Genetic modification of oncolytic viruses to enhance antitumor immunity

2020/1/1

Alyssa Vito
Alyssa Vito

H-Index: 5

See List of Professors in Alyssa Vito University(McMaster University)

Co-Authors

academic-engine